"Mesothelioma attorney" - Reports Highlight Recent Developments From Lentigen

Reports Highlight Recent Developments From Lentigen
Lentigen Corp. announced that it has received U.S. National Institute of Health (NIH) small business innovation research funding to develop an improved and novel therapy for patients with chronic lymphocytic leukemia (CLL) and other hematological malignancies. The goal of the proposed project is to demonstrate the ability of Lentigen's lentiviral vector (LV) to provide an efficient and clinically feasible delivery system for CD40-ligand (CD154), a well-known stimulator of T cells in CLL. CLL is a progressive disease for which no cure is available. The cancer produces abnormal white blood cells that are very long-lived and thus accumulate slowly, as opposed to the relatively short-lived and rapidly accumulating cells that characteriz...

Brain Mets and Spread to Bone Tarceva Not Working?
Hello, Reading some of the messages, if my Mom has been on Tarceva a year and a half, and they found new spots in her brain, and then Friday found it on her back(I'm not sure if in spine or bone) does this mean the Tarceva has stopped working? They said something about it is not crossing the blood brain barrier, is this typical of what others are finding? Or should she be on a higher dose? She is down to 75mg/day. Or is it time to switch to a new drug?We have a doctor's appointment Tues. Thank you for any info! Diana...

Pleural effusion
Title: Pleural effusion
Category: Medical Dictionary
Created: 3/26/1998 2:28:00 PM
Last Editorial Review: 11/21/2003

Cancer Causes
Title: Cancer Causes
Category: Diseases and Conditions
Created: 12/31/1997
Last Editorial Review: 4/23/2002

Research From School Of Medicine Yields New Findings On Lung Cancer Prevention
A report, "Smoking relapse during the first year after treatment for early-stage non-small-cell lung cancer," is newly published data in Cancer Epidemiology, Biomarkers & Prevention. "Non-small-cell lung cancer patients who continue to smoke after cancer diagnosis are more likely to experience disease recurrence, decreased treatment efficacy, and treatment complications. Despite this, many continue to smoke, with estimates ranging from 13% to approximately 60%," investigators in the United States report. "Participants were 154 early-stage, non-small-cell lung cancer patients who had smoked within 3 months before surgery. Patients were followed for 12 months after surgery to assess smoking status and duration of continuous abstinence afte...